Novel and potent human and rat β3-Adrenergic receptor agonists containing substituted 3-indolylalkylamines
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (7) , 1301-1305
- https://doi.org/10.1016/s0960-894x(03)00073-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in HumansCurrent Pharmaceutical Design, 2001
- β3 Adrenergic Receptor Agonists for the Treatment of ObesityPublished by Elsevier ,1998
- STRUCTURE AND FUNCTION OF THE β3-ADRENERGIC RECEPTORAnnual Review of Pharmacology and Toxicology, 1997
- Clinical pharmacology of β3‐adrenoceptorsBritish Journal of Clinical Pharmacology, 1996
- Synthesis and β-adrenergic activity of atypical β-adrenergic phenylethanolaminotetralin stereoisomersEuropean Journal of Medicinal Chemistry, 1994
- CL 316,243Drugs of the Future, 1994
- BRL 35135Drugs of the Future, 1991
- Molecular Characterization of the Human β 3 -Adrenergic ReceptorScience, 1989
- The brown adipocyte β-adrenoceptorProceedings of the Nutrition Society, 1989
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967